Exploring the Oxford-AstraZeneca Eugenics Links

STORY AT-A-GLANCE

  • The AstraZeneca vaccine is being promoted for developing countries, in part because it doesn’t require the deep-freeze cold storage that mRNA vaccines do, so the logistics surrounding distribution are less complex
  • Patents and royalties for the AstraZeneca vaccine are held by a private company called Vaccitech, investors of which include Google Ventures, the Wellcome Trust, the Chinese branch of Sequoia Capital, the Chinese drug company Fosun Pharma and the British government
  • While AstraZeneca has promised it will not make any profit from its vaccine, there’s a time limit on this pledge. The not-for-profit vow expires once the pandemic is over, and AstraZeneca itself appears to have a say when it comes to declaring the end date
  • The AstraZeneca COVID-19 vaccine was co-developed by Adrian Hill, who has long-term ties to the British eugenics movement through his work with the Wellcome Trust’s Centre for Human Genetics and affiliation with the Galton Institute, formerly the U.K. Eugenics Society
  • Members of the Galton Institute have called for population reduction in Latin America, South and Southeast Asia and Africa, the very areas where the AstraZeneca vaccine is being promoted

Continue reading